Genetic Evidence for Protective Effects of Angiotensin-Converting Enzyme Against Alzheimer Disease But Not Other Neurodegenerative Diseases in European Populations

BACKGROUND AND OBJECTIVES: Angiotensin-converting enzyme (ACE) inhibitors are a commonly prescribed class of medication used to treat heart failure, hypertension, and chronic kidney disease. However, previous observational studies have shown conflicting directions of associations between ACE inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryan, David K., Karhunen, Ville, Su, Bowen, Traylor, Matthew, Richardson, Tom G., Burgess, Stephen, Tzoulaki, Ioanna, Gill, Dipender
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425221/
https://www.ncbi.nlm.nih.gov/pubmed/36046424
http://dx.doi.org/10.1212/NXG.0000000000200014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425221/
https://www.ncbi.nlm.nih.gov/pubmed/36046424
http://dx.doi.org/10.1212/NXG.0000000000200014

Ejemplares similares